Market attention turns to Cardinal Health after media endorsement

Jim Cramer’s recent endorsement of Cardinal Health (CAH), highlighting its shift toward broader client services, quarterly estimate beats, and current valuation, has pushed the distributor into sharper focus for healthcare investors.

Despite the latest dip, with a 7 day share price return of 5.37% and a 90 day share price return of 6.63% in the red, Cardinal Health’s 1 year total shareholder return of 46.2% and 5 year total shareholder return of 264.36% point to longer term performance that frames Cramer’s comments against a backdrop of historical value creation.

If this kind of healthcare story has your attention, it could be a good moment to broaden your watchlist with 33 healthcare AI stocks

With Cardinal Health still trading below analyst price targets and an intrinsic value estimate that suggests a sizeable discount, the real question is whether investors are looking at a genuine opportunity or a stock already pricing in future growth.

Most Popular Narrative: 19.5% Undervalued

Cardinal Health's most followed narrative puts fair value at $248.27 per share, well above the last close of $199.85. This is driving a lot of interest in how that gap is justified.

The company's investments in automation, advanced supply chain technology, and new distribution centers are expected to deliver long-term operational efficiencies and cost savings, supporting improved net margins and free cash flow as healthcare shifts to value-based and outpatient models.

Curious what kind of revenue build, margin lift, and earnings profile need to line up to support that valuation gap? The narrative focuses on compounded top line expansion, gradual profitability improvement, and a future earnings multiple that assumes investors continue to place a premium on this distribution and services model.

Result: Fair Value of $248.27 (UNDERVALUED)

However, you also need to weigh tighter regulation and reimbursement changes, along with any major customer losses, which could pressure margins and challenge that upside story.

Another View: Market Pricing Versus Fair Ratio

The narrative sees Cardinal Health as 19.5% undervalued, yet the current P/E of 28.3x sits above both the US Healthcare industry at 24.3x and peers at 24.2x, while the fair ratio is 31x. That mix of discount to fair value and premium to peers raises a simple question: which signal do you trust more?

Next Steps

All this mixed sentiment can feel like a lot to process, so it helps to move fast, look at the numbers yourself, and decide what really matters for your portfolio based on 4 key rewards and 2 important warning signs.

Looking for more investment ideas?

If Cardinal Health has you thinking more broadly about healthcare and beyond, this can be a good time to widen your opportunity set instead of stopping at one idea.

• Zero in on quality at a discount by checking stocks that screen as attractively priced with solid fundamentals through 54 high quality undervalued stocks.
• Prioritise resilience by reviewing companies that stand out for financial strength using the solid balance sheet and fundamentals stocks screener (42 results).
• Spot potential early movers by scanning for lesser known names with strong metrics via the screener containing 25 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.